Drūl, founded with the mission to revolutionize oral health diagnostics, focuses on creating at-home diagnostic devices that detect oral diseases using saliva samples. Their core product isolates harmful bacteria from saliva, quantifies bacterial concentration, and identifies critical biomarkers to detect early onset of oral diseases like cavities and gum disease. Drūl aims to provide a quick and convenient way for individuals to monitor their oral health, thereby preventing irreversible damage and promoting overall well-being.
Notable affiliated individuals and investors have yet to be publicly disclosed. However, Drūl has made significant strides in the health tech industry by offering a practical solution for early disease detection. Their innovative approach has the potential to reduce the prevalence of severe oral health issues globally, making a substantial impact on preventive healthcare.
